HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI-α silencing and overexpression.

AbstractBACKGROUND:
The consequence of Rho GDP dissociation inhibitor alpha (RhoGDIα) activity on migration and invasion of estrogen receptor positive (ER+) and negative (ER-) breast cancer cells has not been studied using the proteomic approach. Changes in expression of RhoGDIα and other proteins interacting directly or indirectly with RhoGDIα in MCF7 and MDA-MB-231, with different metastatic potentials is of particular interest.
MATERIALS AND METHODS:
ER+ MCF7 and ER- MDA-MB-231 cell lines were subjected to two-dimensional electrophoresis (2-DE) and spots of interest were identified by matrix-assisted laser desorption/ionization time of- flight/time- of-flight (MALDI-TOF/TOF) mass spectrometry (MS) analysis after downregulation of RhoGDIα using short interfering RNA (siRNA) and upregulated using GFP-tagged ORF clone of RhoGDIα.
RESULTS:
The results showed a total of 35 proteins that were either up- or down-regulated in these cells. Here we identifed 9 and 15 proteins differentially expressed with silencing of RhoGDIα in MCF-7 and the MDA-MB-231 cells, respectively. In addition, 10 proteins were differentially expressed in the upregulation of RhoGDIα in MCF7, while only one protein was identified in the upregulation of RhoGDIα in MDA-MB-231. Based on the biological functions of these proteins, the results revealed that proteins involved in cell migration are more strongly altered with RhoGDI-α activity. Although several of these proteins have been previously indicated in tumorigenesis and invasiveness of breast cancer cells, some ohave not been previously reported to be involved in breast cancer migration. Hence, these proteins may serve as useful candidate biomarkers for tumorigenesis and invasiveness of breast cancer cells.
CONCLUSIONS:
Future studies are needed to determine the mechanisms by which these proteins regulate cell migration. The combination of RhoGDIα with other potential biomarkers may be a more promising approach in the inhibition of breast cancer cell migration.
AuthorsSomayeh Hooshmand, Abbas Ghaderi, Khatijah Yusoff, Karuppiah Thilakavathy, Rozita Rosli, Zahra Mojtahedi
JournalAsian Pacific journal of cancer prevention : APJCP (Asian Pac J Cancer Prev) Vol. 15 Issue 7 Pg. 3311-7 ( 2014) ISSN: 2476-762X [Electronic] Thailand
PMID24815488 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ARHGDIB protein, human
  • Proteins
  • RNA, Messenger
  • RNA, Small Interfering
  • Receptors, Estrogen
  • rho Guanine Nucleotide Dissociation Inhibitor alpha
  • rho Guanine Nucleotide Dissociation Inhibitor beta
Topics
  • Breast Neoplasms (genetics)
  • Carcinogenesis (genetics)
  • Cell Line, Tumor
  • Cell Movement (genetics)
  • Cell Proliferation (genetics)
  • Female
  • Gene Expression (genetics)
  • Humans
  • MCF-7 Cells
  • Neoplasm Invasiveness (genetics)
  • Protein Biosynthesis (genetics)
  • Proteins (metabolism)
  • Proteomics
  • RNA Interference
  • RNA, Messenger (genetics)
  • RNA, Small Interfering
  • Receptors, Estrogen (metabolism)
  • rho Guanine Nucleotide Dissociation Inhibitor alpha (biosynthesis, genetics)
  • rho Guanine Nucleotide Dissociation Inhibitor beta (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: